Robert M. Weisbrod

3.8k total citations · 1 hit paper
48 papers, 3.1k citations indexed

About

Robert M. Weisbrod is a scholar working on Physiology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robert M. Weisbrod has authored 48 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Physiology, 23 papers in Molecular Biology and 21 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robert M. Weisbrod's work include Nitric Oxide and Endothelin Effects (24 papers), Cardiovascular Disease and Adiposity (6 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Robert M. Weisbrod is often cited by papers focused on Nitric Oxide and Endothelin Effects (24 papers), Cardiovascular Disease and Adiposity (6 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Robert M. Weisbrod collaborates with scholars based in United States, China and Australia. Robert M. Weisbrod's co-authors include Richard A. Cohen, Takeshi Adachi, Victoria M. Bolotina, David R. Pimentel, Jia Ying, Belay Tesfamariam, Christian Schöneich, Victor S. Sharov, Marion Gericke and Mohammad Ali Yaghoubi and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Medicine.

In The Last Decade

Robert M. Weisbrod

47 papers receiving 3.0k citations

Hit Papers

S-Glutathiolation by peroxynitrite activates SERCA during... 2004 2026 2011 2018 2004 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert M. Weisbrod United States 31 1.3k 1.2k 955 381 348 48 3.1k
Georg Kojda Germany 32 2.1k 1.6× 1.1k 0.9× 1.6k 1.7× 481 1.3× 597 1.7× 108 4.8k
Xin L. United States 27 1.0k 0.8× 1.3k 1.1× 1.1k 1.1× 172 0.5× 294 0.8× 44 3.4k
Masanori Takaoka Japan 36 1.8k 1.4× 1.2k 1.0× 1.2k 1.2× 347 0.9× 281 0.8× 144 3.8k
Johannes-Peter Stasch Germany 22 1.3k 1.0× 1.0k 0.8× 918 1.0× 225 0.6× 247 0.7× 31 2.7k
Mark J. Crabtree United Kingdom 32 1.3k 1.0× 1.1k 0.9× 802 0.8× 397 1.0× 560 1.6× 70 3.4k
Yoshihiro Taniyama Japan 22 1.1k 0.9× 1.4k 1.2× 676 0.7× 370 1.0× 679 2.0× 32 3.3k
Carolyn J. Smith United States 31 1.3k 1.0× 1.8k 1.5× 989 1.0× 313 0.8× 188 0.5× 46 3.7k
Ai-Ping Zou United States 41 1.4k 1.1× 1.4k 1.1× 953 1.0× 671 1.8× 185 0.5× 57 3.8k
W. Ross Tracey United States 31 1.2k 0.9× 929 0.8× 569 0.6× 287 0.8× 194 0.6× 41 2.8k
Joachim Hoyer Germany 34 1.3k 1.0× 1.9k 1.6× 1.3k 1.3× 327 0.9× 179 0.5× 85 3.9k

Countries citing papers authored by Robert M. Weisbrod

Since Specialization
Citations

This map shows the geographic impact of Robert M. Weisbrod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Weisbrod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Weisbrod more than expected).

Fields of papers citing papers by Robert M. Weisbrod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert M. Weisbrod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Weisbrod. The network helps show where Robert M. Weisbrod may publish in the future.

Co-authorship network of co-authors of Robert M. Weisbrod

This figure shows the co-authorship network connecting the top 25 collaborators of Robert M. Weisbrod. A scholar is included among the top collaborators of Robert M. Weisbrod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert M. Weisbrod. Robert M. Weisbrod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Majid, Sana, Robert M. Weisbrod, Jessica L. Fetterman, et al.. (2023). Pod-based e-liquids impair human vascular endothelial cell function. PLoS ONE. 18(1). e0280674–e0280674. 13 indexed citations
2.
Majid, Sana, Jessica L. Fetterman, Robert M. Weisbrod, et al.. (2022). Abstract 15569: Association of Volatile Organic Compound Levels With Pod-Based Electronic Cigarette-Induced Changes in Vascular Function of Young Adults. Circulation. 146(Suppl_1). 1 indexed citations
3.
Rizvi, Syed Husain Mustafa, Ди Шао, Yuko Tsukahara, et al.. (2021). Oxidized GAPDH transfers S-glutathionylation to a nuclear protein Sirtuin-1 leading to apoptosis. Free Radical Biology and Medicine. 174. 73–83. 35 indexed citations
4.
Majid, Sana, Rachel J. Keith, Jessica L. Fetterman, et al.. (2021). Lipid profiles in users of combustible and electronic cigarettes. Vascular Medicine. 26(5). 483–488. 13 indexed citations
5.
Fetterman, Jessica L., Robert M. Weisbrod, Bihua Feng, et al.. (2018). Flavorings in Tobacco Products Induce Endothelial Cell Dysfunction. Arteriosclerosis Thrombosis and Vascular Biology. 38(7). 1607–1615. 105 indexed citations
6.
Wu, Xiaojuan, Alok R. Khandelwal, Zaicheng Xu, et al.. (2017). Endothelial Nox4-based NADPH oxidase regulates atherosclerosis via soluble epoxide hydrolase. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(6). 1382–1391. 35 indexed citations
7.
Tong, Xiaoyong, Alok R. Khandelwal, Xiaojuan Wu, et al.. (2016). Pro-atherogenic role of smooth muscle Nox4-based NADPH oxidase. Journal of Molecular and Cellular Cardiology. 92. 30–40. 42 indexed citations
8.
Fetterman, Jessica L., Monica Holbrook, David G. Westbrook, et al.. (2016). Mitochondrial DNA damage and vascular function in patients with diabetes mellitus and atherosclerotic cardiovascular disease. Cardiovascular Diabetology. 15(1). 53–53. 91 indexed citations
9.
Han, Jingyan, Robert M. Weisbrod, Di Shao, et al.. (2016). The redox mechanism for vascular barrier dysfunction associated with metabolic disorders: Glutathionylation of Rac1 in endothelial cells. Redox Biology. 9. 306–319. 52 indexed citations
10.
Qin, Zhexue, Xiuyun Hou, Robert M. Weisbrod, et al.. (2014). Nox2 mediates high fat high sucrose diet-induced nitric oxide dysfunction and inflammation in aortic smooth muscle cells. Journal of Molecular and Cellular Cardiology. 72. 56–63. 26 indexed citations
11.
Thompson, Melissa D., Yu Mei, Robert M. Weisbrod, et al.. (2014). Glutathione Adducts on Sarcoplasmic/Endoplasmic Reticulum Ca2+ ATPase Cys-674 Regulate Endothelial Cell Calcium Stores and Angiogenic Function as Well as Promote Ischemic Blood Flow Recovery. Journal of Biological Chemistry. 289(29). 19907–19916. 51 indexed citations
12.
Liu, Chia‐Chi, Keyvan Karimi Galougahi, Robert M. Weisbrod, et al.. (2013). Oxidative inhibition of the vascular Na+-K+ pump via NADPH oxidase-dependent β1-subunit glutathionylation: Implications for angiotensin II-induced vascular dysfunction. Free Radical Biology and Medicine. 65. 563–572. 28 indexed citations
13.
Evangelista, Alicia M., Melissa D. Thompson, Robert M. Weisbrod, et al.. (2012). Redox Regulation of SERCA2 Is Required for Vascular Endothelial Growth Factor-Induced Signaling and Endothelial Cell Migration. Antioxidants and Redox Signaling. 17(8). 1099–1108. 49 indexed citations
14.
Tong, Xiaoyong, Xiuyun Hou, David Jourd’heuil, Robert M. Weisbrod, & Richard A. Cohen. (2010). Upregulation of Nox4 by TGFβ1 Oxidizes SERCA and Inhibits NO in Arterial Smooth Muscle of the Prediabetic Zucker Rat. Circulation Research. 107(8). 975–983. 93 indexed citations
15.
Weisbrod, Robert M., et al.. (1998). Evidence that additional mechanisms to cyclic GMP mediate the decrease in intracellular calcium and relaxation of rabbit aortic smooth muscle to nitric oxide. British Journal of Pharmacology. 125(8). 1695–1707. 56 indexed citations
16.
Celander, Malin, Robert M. Weisbrod, & John J. Stegeman. (1997). Glucocorticoid Potentiation of Cytochrome P4501A1 Induction by 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Porcine and Human Endothelial Cells in Culture. Biochemical and Biophysical Research Communications. 232(3). 749–753. 36 indexed citations
17.
Tesfamariam, Belay, James Palacino, Robert M. Weisbrod, & Richard A. Cohen. (1993). Aldose Reductase Inhibition Restores Endothelial Cell Function in Diabetic Rabbit Aorta. Journal of Cardiovascular Pharmacology. 21(2). 205–205. 83 indexed citations
18.
Tesfamariam, Belay, Robert M. Weisbrod, & Richard A. Cohen. (1992). Cyclic GMP Modulators on Vascular Adrenergic Neurotransmission. Journal of Vascular Research. 29(5). 396–404. 14 indexed citations
19.
Tesfamariam, Belay, Robert M. Weisbrod, & Richard A. Cohen. (1989). Augmented Adrenergic Contractions of Carotid Arteries from Cholesterol-Fed Rabbits Due to Endothelial Cell Dysfunction. Journal of Cardiovascular Pharmacology. 13(6). 820–825. 24 indexed citations
20.
Cohen, Richard A., K M Zitnay, Robert M. Weisbrod, & Belay Tesfamariam. (1988). Influence of the endothelium on tone and the response of isolated pig coronary artery to norepinephrine.. Journal of Pharmacology and Experimental Therapeutics. 244(2). 550–555. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026